Tag: Gantenerumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Gantenerumab

Analysis: Rival treatments may help justify FDA gamble with Biogen Alzheimer's drug

Added to Collection on: 2021-06-18 10:52:30

Tags for this article:

Health sciences
Life Sciences
Health
Monoclonal antibodies
Food and Drug Administration
Amyloidosis
Pharmaceutical industry
Aducanumab
Donanemab
Alzheimer's disease
Biogen
Clinical trial
Gantenerumab

Click the tags to see associated articles and topics

View Article Details
Roche's Alzheimer's antibody lowers biomarkers in inherited form of disease, though impact on ...

Added to Collection on: 2021-06-21 15:00:00

Tags for this article:

Monoclonal antibodies
Treatment of Alzheimer's disease
Alzheimer's disease
Branches of biology
Biology
Neuroscience
Amyloidosis
Solanezumab
Gantenerumab
Donanemab
Crenezumab
ELI LILLY AND

Click the tags to see associated articles and topics

View Article Details
Roche gantenerumab improves biomarkers in inherited form of Alzheimer's disease

Added to Collection on: 2021-06-22 11:37:30

Tags for this article:

Branches of biology
Monoclonal antibodies
Biology
Treatment of Alzheimer's disease
Amyloidosis
Neuroscience
Alzheimer's disease
Solanezumab
Amyloid beta
Gantenerumab

Click the tags to see associated articles and topics

View Article Details
Roche to seek early FDA approval for Alzheimer's drug, following Lilly through door blown open by ...

Added to Collection on: 2021-07-01 12:00:00

Tags for this article:

Life Sciences
Health sciences
Health care
Monoclonal antibodies
Treatment of Alzheimer's disease
Food and Drug Administration
Pharmacy
Aducanumab
Alzheimer's disease
Biogen
Donanemab
Breakthrough therapy
Gantenerumab

Click the tags to see associated articles and topics

View Article Details
Roche, following setbacks, turns to its next Alzheimer's drug | BioPharma Dive

Added to Collection on: 2024-03-12 04:40:06

Tags for this article:

Alzheimer's disease
Orphan drugs
Donanemab
Amyloidosis
Lecanemab
Crenezumab
Biogen
Gantenerumab
Brian Abrahams

Click the tags to see associated articles and topics

View Article Details
Phase 3 TRAILRUNNER-ALZ 3 to Test Effects of IgG1 Monoclonal Antibody Remternetug in ...

Added to Collection on: 2024-10-30 22:08:00

Tags for this article:

Alzheimer's disease
Amyloidosis
Donanemab
Biomarkers
Gantenerumab
Amyloid
Lecanemab
Crenezumab
Eli Lilly
Madrid
Spain

Click the tags to see associated articles and topics

View Article Details
7 Alzheimer's and Parkinson's Programs Discarded in 2024 - BioSpace

Added to Collection on: 2024-11-04 05:07:24

Tags for this article:

Lecanemab
Seltorexant
Donanemab
Crenezumab
Biogen
Gantenerumab
Eli Lilly
Graig Suvannevejh

Click the tags to see associated articles and topics

View Article Details
Trontinemab Data Strengthen Hope for Brain Shuttles | ALZFORUM

Added to Collection on: 2024-11-09 00:00:46

Tags for this article:

Amyloidosis
Alzheimer's disease
Biomarkers
Amyloid-related imaging abnormalities
Magnetic resonance imaging
Neuroimaging
Amyloid beta
Lecanemab
Cerebral amyloid angiopathy
Trontinemab
Donanemab
Amyloid plaques
Gantenerumab

Click the tags to see associated articles and topics

View Article Details
Anti-amyloid drug shows signs of preventing Alzheimer's dementia - WashU Medicine

Added to Collection on: 2025-03-19 23:34:15

Tags for this article:

Cognitive disorders
Aging-associated diseases
Learning disabilities
Dementia
Lecanemab
Alzheimer's disease
Anti-amyloid drugs
Steven T. DeKosky
Draft:Eisai's Alzheimers Trial
Gantenerumab
United States

Click the tags to see associated articles and topics

View Article Details
Is Roche's new anti-amyloid drug a step forward for Alzheimer's disease treatment?

Added to Collection on: 2025-09-17 18:38:50

Tags for this article:

Amyloidosis
Histopathology
Alzheimer's disease
Anti-amyloid antibodies
Trontinemab
Lecanemab
Gantenerumab
Aducanumab
Donanemab
Amyloid-related imaging abnormalities
Biogen
Brainshuttle
Mitzi Gonzales

Click the tags to see associated articles and topics

View Article Details
Book a Demo